Torreta, Renato V.

HRN: 18-77-00  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/09/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/09/2025
09/16/2025
IV
500mg
Q8h
Obstructive Jaundice Sec To Cholecystolithiasis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines